COST EFFECTIVENESS ANALYSIS OF RIVAROXABAN FOR TREATMENT OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN GREECE

被引：0
|
作者：
Gourzoulidis, G. [1 ]
Kourlaba, G. [2 ]
Kakisis, J. [3 ]
Matsagkas, M. [4 ]
Giannakoulas, G. [5 ]
Gourgoulianis, K. [6 ]
Vassilakopoulos, T. [7 ]
Arzoumanidou, D. [8 ]
Maniadakis, N. [1 ]
机构：
[1] Natl Sch Publ Hlth, Athens, Greece
[2] EVROSTON LP, Athens, Greece
[3] Univ Athens, Sch Med, Attikon Hosp, Athens, Greece
[4] Univ Ioannina, Ioannina, Greece
[5] Aristotle Univ Thessaloniki, AHEPA Hosp, Thessaloniki, Greece
[6] Univ Thessaly, Univ Hosp Larissa, Larisa, Greece
[7] Univ Athens Med Sch, Evangelismos Hosp, Athens, Greece
[8] Bayer Hellas AG, Athens, Greece
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1200
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS32
引用
收藏
页码：A554 / A554
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece
    George Gourzoulidis
    Georgia Kourlaba
    John Kakisis
    Mitiadis Matsagkas
    George Giannakoulas
    Konstantinos I. Gourgoulianis
    Theodoros Vassilakopoulos
    Nikos Maniadakis
    Clinical Drug Investigation, 2017, 37 : 833 - 844
  • [2] Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece
    Gourzoulidis, George
    Kourlaba, Georgia
    Kakisis, John
    Matsagkas, Mitiadis
    Giannakoulas, George
    Gourgoulianis, Konstantinos I.
    Vassilakopoulos, Theodoros
    Maniadakis, Nikos
    CLINICAL DRUG INVESTIGATION, 2017, 37 (09) : 833 - 844
  • [3] Cost Effectiveness of the Prevention and Treatment of Deep Vein Thrombosis and Pulmonary Embolism
    David R. Anderson
    Bernie J. O’Brien
    PharmacoEconomics, 1997, 12 : 17 - 29
  • [4] Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism
    Anderson, DR
    OBrien, BJ
    PHARMACOECONOMICS, 1997, 12 (01) : 17 - 29
  • [5] AN ANALYSIS OF THE EFFICACY AND SAFETY OF EDOXABAN IN COMPARISON WITH RIVAROXABAN IN THE TREATMENT OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
    van Hout, B.
    Gumbs, P. D.
    Cohen, A. T.
    Verhamme, P.
    VALUE IN HEALTH, 2016, 19 (07) : A637 - A638
  • [6] A Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin for Deep Vein Thrombosis (DVT) Treatment in Ethiopia
    Derseh, Manaye Tamrie
    Solomon, Kiflom
    Tamene, Wasihun
    Beneberu, Wosenie
    Yayehrad, Ashagrachew Tewabe
    Ambaye, Abyou Seyfu
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 821 - 834
  • [7] ECONOMIC EVALUATION OF RIVAROXABAN IN THE TREATMENT OF DEEP VEIN THROMBOSIS IN GREECE
    Kourlaba, G.
    Maniadakis, N.
    Giannoukas, A.
    Katsamouris, A.
    Katsenis, K.
    Lazarides, M.
    Matsagas, M.
    Lowin, J.
    McLeod, E. J.
    Bamber, L.
    VALUE IN HEALTH, 2012, 15 (07) : A372 - A372
  • [8] Treatment of deep vein thrombosis and pulmonary embolism
    Schellong, S. M.
    INTERNIST, 2011, 52 (11): : 1284 - +
  • [9] The treatment of deep vein thrombosis and pulmonary embolism
    Turkstra, F
    Koopman, MMW
    Buller, HR
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (01) : 489 - 496
  • [10] Comparative Efficacy and Safety Of Dabigatran Etexilate and Rivaroxaban For The Treatment Of Deep Vein Thrombosis and Pulmonary Embolism
    Clemens, Andreas
    Abeysinghe, Shaun
    Gonschior, Ann-Katrin
    Hoesel, Volker
    Lock, Sarah
    Wolowacz, Sorrel E.
    Woods, Mathew
    Zimovetz, Evelina
    BLOOD, 2013, 122 (21)
12345